Dahham Alsoud

Hi there!

I am Dahham, a physician-scientist performing postdoctoral research at Stanford University School of Medicine in the research group of Prof. Dr. Michael J. Rosen, with a focus on inflammatory bowel disease. My work combines advanced statistical modelling and bioinformatics, leveraging multi-omics data from the CAPTURE IBD cohort to uncover the molecular and clinical determinants of therapy outcomes. Through this research, I aim to reduce trial-and-error treatment strategies, strengthen evidence-based clinical decision-making, and ultimately improve outcomes and quality of life for individuals living with inflammatory bowel disease.

I performed my PhD research at KU Leuven under the supervision of Prof. Dr. Séverine Vermeire and Prof. Dr. Bram Verstockt. My doctoral thesis, entitled Understanding Therapeutic Outcomes in Inflammatory Bowel Diseases: Insights from Clinicomics, Proteomics, and Transcriptomics, integrated clinical prediction, serum proteomic profiling, and whole-blood transcriptomic analyses to examine heterogeneity in treatment response, therapeutic resistance, and the molecular rationale for advanced combination treatment strategies. By linking patient-level clinical data with molecular signatures, my work sought to move treatment selection beyond empiricism and toward more individualized therapeutic decision-making.

I earned my MD from Damascus University and a Master of Science in Health Care Management and Policy from KU Leuven. My academic work has resulted in multiple peer-reviewed publications in inflammatory bowel disease, spanning predictive modelling, biomarker discovery, precision pharmacology, and the integration of multi-omics data to support individualized therapy selection. Beyond my publications, I serve as an Editorial Fellow for Basic and Translational Science at Inflammatory Bowel Diseases and have contributed to the peer review of more than 100 manuscripts in the field of inflammatory bowel disease.